Scientific approaches to development of medicinal formulation based on biotechnological substance
Abramovich, R.A.; Bykov, V.A.; Elagina, I.A.; Papazova, N.A.; Vorob'ev, A.N.
Antibiotiki i Khimioterapiia 57(1-2): 13-16
2012
ISSN/ISBN: 0235-2990 PMID: 22741196 Document Number: 661157
The study demonstrated possible design of a medicinal formulation in the form of suppositories comprising human recombinant interferon-alpha2 and dry aloe extract. The approaches to the development of the suppositories were technology-derived. No interaction between the active and auxiliary components was proved by solid state 1H-NMR spectroscopy. The specific activity of the drug was investigated.
Document emailed within 1 workday
Related Documents
Suzuki, H.; Noguchi, M.; Harada, M. 1987: Search for a marker substance of Cinnamomi cortex leading to quality evaluation of a Chinese-medicinal formulation "gorei-san" Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 105: 7-12Mashkovskiĭ, M.D. 1982: Current approaches to the development of new pharmacologically active (medicinal) substances Vestnik Akademii Meditsinskikh Nauk SSSR 1982(5): 9-14
Brodniewicz-Proba, T. 2008: The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products Acta Poloniae Pharmaceutica 65(6): 641-645
Kolár, J.; Svejdová, J. 2005: Prescription and structure of formulation of medicinal preparations in a pharmacy. Ii Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 54(1): 29-33
Hamilton, J.; Saylor, B.; Meininger, L. 1998: The development of a culture-based substance abuse treatment program in the Kuskokwim Delta, Alaska International Journal of Circumpolar Health 57 Suppl. 1: 482-484
Krasovskiĭ, G.N.; Egorova, N.A. 1980: Prospects for the development of methods of predicting safe substance levels based on "structure-activity" relationships Vestnik Akademii Meditsinskikh Nauk SSSR 7: 88-95
André, F.E. 2002: How the research-based industry approaches vaccine development and establishes priorities Developments in Biologicals 110: 25-29
Subert, J.; Kolár, J. 2012: Standard prescriptions for the formulation of medicinal preparations in pharmacies V. The collection Dermatologische Magistralrezepturen der Schweiz Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 61(4): 159-162
Helsing, E. 1995: The scientific basis for the formulation of a nutrition policy Voprosy Pitaniia 3: 3-8
Williams, R.L. 2002: The pharmacopeial perspective in accelerating the development and availability of biologicals and biotechnological-derived products Developments in Biologicals 109: 137-142
Oxford, J.S.; Jeffs, S.A. 1996: New scientific developments towards an AIDS vaccine: report on a workshop organized by EU programme EVA entitled Novel approaches to AIDS vaccine development held at the Institut Pasteur, Paris. 16-17 November 1995 Vaccine 14(17-18): 1712-1717
Oxford, J.S.; Jeffs, S.A. 1996: New scientific developments towards an AIDS vaccine: report on a workshop organized by EU programme EVA entitled Novel approaches to AIDS vaccine development held at the Institut Pasteur, Paris. 16-17 November 1995 Vaccine 14(17-18): 1712-1717
Khedkar, S.A. 2010: Current computational approaches in medicinal chemistry Current Topics in Medicinal Chemistry 10(1): 1-2
Vaidya, A.B.; Antarkar, V.D. 1994: New drugs from medicinal plants: opportunities and approaches Journal of the Association of Physicians of India 42(3): 221
Straney, L.D. 2007: Gratuitous and without scientific substance Medical Journal of Australia 187(7): 422; Author Reply 423-4
Baskova, I.P.; Zavalova, L.L.; Basanova, A.V.; Aquejouf, O.M.; Azougagh-Oualane, F.; Doutremepuich, C. 1995: Antithrombotic effect of piavit--a substance from the medicinal leech (Hirudo medicinalis), containing prostanoid and destabilase fractions Biokhimiia 60(11): 1775-1783
Cornacchione, S.; Sadick, N.S.; Neveu, M.; Talbourdet, S.; Lazou, K.; Viron, C.; Renimel, I.; de Quéral, D.; Kurfurst, R.; Schnebert, S.; Heusèle, C.; André, P.; Perrier, E. 2007: In vivo skin antioxidant effect of a new combination based on a specific Vitis vinifera shoot extract and a biotechnological extract Journal of Drugs in Dermatology: Jdd 6(6 Suppl): S8-13
Iizuka, R.; Mataix, A. 1982: Scientific and ethical approaches to human reproduction Kango Tenbo. Japanese Journal of Nursing Science 7(4): 328-332
Paszun, S.K.; Stanisz, B.; Pawłowski, W. 2012: Rapid and simple stability indicating HPLC method for the determination of cilazapril in pure substance and pharmaceutical formulation in comparison with classic and derivative spectrophotometric methods Acta Poloniae Pharmaceutica 69(2): 193-201
Fabio, S. di; Cianfriglia, M.; Flego, M.; Ascione, A.; Gellini, M.; Zamboni, S.; Binelli, A.; Carlini, F.; Germinario, E.; Vella, S. 2006: Animal HU-SCID model of vaginal transmission of HIV-1 for the preclinical evaluation of microbicides. Development of peptidomimetics and mini-antibodies as a new class of microbicides of biotechnological origin Rapporti ISTISAN Istituto Superiore di Sanita (06/50): 298-301